🇺🇸 Rivaroxaban 2.5mg in United States

8 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Haemorrhage — 1 report (12.5%)
  2. Incision Site Haemorrhage — 1 report (12.5%)
  3. Muscle Graft — 1 report (12.5%)
  4. Post Procedural Complication — 1 report (12.5%)
  5. Pulmonary Mass — 1 report (12.5%)
  6. Red Blood Cell Count Decreased — 1 report (12.5%)
  7. Tumour Excision — 1 report (12.5%)
  8. Wound — 1 report (12.5%)

Source database →

Rivaroxaban 2.5mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Rivaroxaban 2.5mg approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Rivaroxaban 2.5mg in United States?

Asan Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.